Reply Re: "Reduction in Extraocular Muscle Cross-sectional Area and Correlation With Extraocular Motility and Diplopia Following Teprotumumab for Thyroid Eye Disease"

Ophthalmic Plast Reconstr Surg. 2023 Jul-Aug;39(4):397. doi: 10.1097/IOP.0000000000002455. Epub 2023 Jul 4.

Authors

Edith R Reshef, Marcela Marsiglia, Karim Bouhadjer, Carolina A Chiou, Devin O'Brien-Coon, Katherine L Reinshagen, Suzanne K Freitag

PMID: 37413682
DOI: 10.1097/IOP.0000000000002455

No abstract available

MeSH terms

Antibodies, Monoclonal, Humanized
Diplopia / chemically induced
Diplopia / diagnosis
Graves Ophthalmopathy* / drug therapy
Humans
Oculomotor Muscles*

Substances

teprotumumab
Antibodies, Monoclonal, Humanized